Zelira Therapeutics (ASX:ZLD) Days Payable : 10,157.87 (As of Dec. 2023)

View and export this data going back to 2003. Start your Free Trial

What is Zelira Therapeutics Days Payable?

Zelira Therapeutics's average Accounts Payable for the six months ended in Dec. 2023 was A$2.62 Mil. Zelira Therapeutics's Cost of Goods Sold for the six months ended in Dec. 2023 was A$0.05 Mil. Hence, Zelira Therapeutics's Days Payable for the six months ended in Dec. 2023 was 10,157.87.

The historical rank and industry rank for Zelira Therapeutics's Days Payable or its related term are showing as below:

ASX:ZLD' s Days Payable Range Over the Past 10 Years
Min: 484.92 Med: 1230.48 Max: 3119.67
Current: 3119.67

During the past 13 years, Zelira Therapeutics's highest Days Payable was 3119.67. The lowest was 484.92. And the median was 1230.48.

ASX:ZLD's Days Payable is ranked better than
91.02% of 724 companies
in the Biotechnology industry
Industry Median: 150.695 vs ASX:ZLD: 3119.67

Zelira Therapeutics's Days Payable increased from Dec. 2022 (2,720.30) to Dec. 2023 (10,157.87). It may suggest that Zelira Therapeutics delayed paying its suppliers.

Zelira Therapeutics Days Payable Historical Data

The historical data trend for Zelira Therapeutics's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zelira Therapeutics Days Payable Chart

Zelira Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Days Payable

Get a 7-Day Free Trial

1,230.48

484.92

1,638.97

Zelira Therapeutics Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Days Payable	Get a 7-Day Free Trial															259.09	696.49	2,720.30	1,470.65	10,157.87

Competitive Comparison of Zelira Therapeutics's Days Payable

For the Biotechnology subindustry, Zelira Therapeutics's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zelira Therapeutics's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zelira Therapeutics's Days Payable distribution charts can be found below:

* The bar in red indicates where Zelira Therapeutics's Days Payable falls into.

Zelira Therapeutics Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Zelira Therapeutics's Days Payable for the fiscal year that ended in Jun. 2023 is calculated as

	Days Payable (A: Jun. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Jun. 2022 )	+	Accounts Payable (A: Jun. 2023 ))	/	count )	/	Cost of Goods Sold (A: Jun. 2023 )	*	Days in Period
=	( (1.51	+	1.741)	/	2 )	/	0.362	*	365
=	1.6255					/	0.362	*	365
=	1,638.97

Zelira Therapeutics's Days Payable for the quarter that ended in Dec. 2023 is calculated as:

	Days Payable (Q: Dec. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Jun. 2023 )	+	Accounts Payable (Q: Dec. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Dec. 2023 )	*	Days in Period
=	( (1.741	+	3.491)	/	2 )	/	0.047	*	365 / 2
=	2.616					/	0.047	*	365 / 2
=	10,157.87

Zelira Therapeutics Days Payable Related Terms

Thank you for viewing the detailed overview of Zelira Therapeutics's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Zelira Therapeutics (ASX:ZLD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zelira Therapeutics Ltd (ASX:ZLD) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

ZLDAF:USA G1G:Germany

Address

101 St George’s Terrace, Level 3, Perth, WA, AUS, 6000

Website

https://www.zeliratx.com

Zelira Therapeutics Ltd is a biotechnology company focused on developing a range of cannabinoid-based formulations for the treatment of various medical conditions in Australia. The company is involved in a human clinical trial program focused on insomnia, autism, and eczema; and a pre-clinical research program to examine the effect of cannabinoids in breast, brain, and pancreatic cancer.

Zelira Therapeutics (ASX:ZLD) Headlines

No Headlines